Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Medicaid Use Of QALYs As Basis Of Drug Coverage Restrictions Would Be Barred By HHS Proposal
Oct 16 2023
•
By
Cathy Kelly
Pushback Against QALYs Comes Amid Increasing US Interest In Doing Cost Effectiveness Analyses • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Market Access
More from Pink Sheet